TY - JOUR
T1 - Isoorientin
T2 - A dietary flavone with the potential to ameliorate diverse metabolic complications
AU - Ziqubu, Khanyisani
AU - Dludla, Phiwayinkosi V.
AU - Joubert, Elizabeth
AU - Muller, Christo J.F.
AU - Louw, Johan
AU - Tiano, Luca
AU - Nkambule, Bongani B.
AU - Kappo, Abidemi P.
AU - Mazibuko-Mbeje, Sithandiwe E.
N1 - Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2020/8
Y1 - 2020/8
N2 - Isoorientin is a natural C-glucosyl flavone that is generating a lot of interest due to its multiple pharmacological activities. Increasing experimental data have shown that the robust antioxidant and anti-inflammatory properties of isoorientin remain important in ameliorating a number of metabolic complications. In fact, plants rich in isoorientin have demonstrated strong ameliorative properties against complications such as hyperglycemia, hyperlipidemia, and insulin resistance. However, while such evidence is accumulating, it has not been reviewed to better inform on the therapeutic potential of this flavone in improving human health. This review examines and extrapolates available literature on the potential beneficial or detrimental effects associated with the use of isoorientin in mitigating metabolic diseases, with a specific focus on diabetes, obesity, and insulin resistance, including associated complications. The discussion includes effective doses in various experimental settings and proposed molecular mechanisms by which isoorientin may exert its therapeutic effects. In addition, the protective effects of extracts of a number of isoorientin-rich plants against metabolic complications will be highlighted.
AB - Isoorientin is a natural C-glucosyl flavone that is generating a lot of interest due to its multiple pharmacological activities. Increasing experimental data have shown that the robust antioxidant and anti-inflammatory properties of isoorientin remain important in ameliorating a number of metabolic complications. In fact, plants rich in isoorientin have demonstrated strong ameliorative properties against complications such as hyperglycemia, hyperlipidemia, and insulin resistance. However, while such evidence is accumulating, it has not been reviewed to better inform on the therapeutic potential of this flavone in improving human health. This review examines and extrapolates available literature on the potential beneficial or detrimental effects associated with the use of isoorientin in mitigating metabolic diseases, with a specific focus on diabetes, obesity, and insulin resistance, including associated complications. The discussion includes effective doses in various experimental settings and proposed molecular mechanisms by which isoorientin may exert its therapeutic effects. In addition, the protective effects of extracts of a number of isoorientin-rich plants against metabolic complications will be highlighted.
KW - Diabetes
KW - Inflammation
KW - Isoorientin
KW - Metabolic disease
KW - Obesity
KW - Oxidative stress
UR - http://www.scopus.com/inward/record.url?scp=85085492774&partnerID=8YFLogxK
U2 - 10.1016/j.phrs.2020.104867
DO - 10.1016/j.phrs.2020.104867
M3 - Review article
C2 - 32407953
AN - SCOPUS:85085492774
SN - 1043-6618
VL - 158
JO - Pharmacological Research
JF - Pharmacological Research
M1 - 104867
ER -